PATRICIA MANGAN: Open Payments
NPI 1629288964 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$53,207 in 84 payments from 7 companies in 2025. Trend: 2023 $57,642 · 2024 $59,002 · 2025 $53,207
Speaker / faculty: $37,506Travel & lodging: $6,936Consulting: $5,362Food & beverage: $1,429Honoraria: $840Speaker / faculty: $635
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 63 | $49,583 |
| GlaxoSmithKline, LLC. | 7 | $1,412 |
| Karyopharm Therapeutics Inc. | 2 | $840 |
| AstraZeneca Pharmaceuticals LP | 6 | $609 |
| GENZYME CORPORATION | 1 | $500 |
| TAIHO ONCOLOGY, INC. | 4 | $190 |
| PFIZER INC. | 1 | $72 |
Products named: RYBREVANT, DARZALEX, TALVEY, XPOVIO, ELREXFIO, CARVYKTI.
Industry payments across PA — which companies pay providers there.
